Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance

P. D. Cole, B. A. Kamen, R. Gorlick, D. Banerjee, A. K. Smith, E. Magill, J. R. Bertino

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Intracellular metabolism of methotrexate (MTX) to MTX-polyglutamates (MTXPG) is one determinant of cytotoxicity. Steady-state accumulation of MTXPG seems to depend on the activity of two enzymes: folylpolyglutamate synthetase (FPGS), which adds glutamate residues, and γ-glutamyl hydrolase (GGH), which removes them. Overexpression of GGH would be expected to decrease intracellular MTXPG, thereby increasing efflux of MTX and decreasing cytotoxicity. Increased expression of GGH has been shown to be associated with resistance to MTX in human sarcoma cell lines and a rat hepatoma cell line. To clarify the specific role of GGH in determining MTX sensitivity, we investigated the phenotype produced by forced GGH overexpression in two cell types. Furthermore, because MTX and folic acid share metabolic pathways, we measured the effects of GGH overexpression on folic acid metabolism. The full-length cDNA for GGH, subcloned into a constitutive expression vector, was transfected into a human fibrosarcoma (HT-1080) and a human breast carcinoma (MCF-7) cell line. Compared with the clones containing an empty vector, the GGH-overexpressing cells express 15- to 30-fold more GGH mRNA, more GGH protein, and 15- to 90-fold more GGH enzyme activity. GGH overexpression altered MTX accumulation and metabolism to long-chain polyglutamates. In contrast to expectations, however, GGH overexpression did not confer resistance to short MTX exposures in either cell line. Changes in MTX metabolism were found to be balanced by alterations in accumulation and metabolism of folic acid. The ratio of MTX: folate accumulation may be a better predictor of MTX cytotoxicity than the accumulation of either alone. We conclude that, at least for these two cell lines, GGH overexpression alone is insufficient to produce clinical resistance to MTX.

Original languageEnglish (US)
Pages (from-to)4599-4604
Number of pages6
JournalCancer Research
Volume61
Issue number11
StatePublished - Jun 1 2001
Externally publishedYes

Fingerprint

Hydrolases
Methotrexate
Glutamic Acid
Polyglutamic Acid
Folic Acid
Cell Line
Fibrosarcoma
MCF-7 Cells
Enzymes
Metabolic Networks and Pathways
Sarcoma
Hepatocellular Carcinoma
Complementary DNA
Clone Cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cole, P. D., Kamen, B. A., Gorlick, R., Banerjee, D., Smith, A. K., Magill, E., & Bertino, J. R. (2001). Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance. Cancer Research, 61(11), 4599-4604.

Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance. / Cole, P. D.; Kamen, B. A.; Gorlick, R.; Banerjee, D.; Smith, A. K.; Magill, E.; Bertino, J. R.

In: Cancer Research, Vol. 61, No. 11, 01.06.2001, p. 4599-4604.

Research output: Contribution to journalArticle

Cole, PD, Kamen, BA, Gorlick, R, Banerjee, D, Smith, AK, Magill, E & Bertino, JR 2001, 'Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance', Cancer Research, vol. 61, no. 11, pp. 4599-4604.
Cole PD, Kamen BA, Gorlick R, Banerjee D, Smith AK, Magill E et al. Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance. Cancer Research. 2001 Jun 1;61(11):4599-4604.
Cole, P. D. ; Kamen, B. A. ; Gorlick, R. ; Banerjee, D. ; Smith, A. K. ; Magill, E. ; Bertino, J. R. / Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance. In: Cancer Research. 2001 ; Vol. 61, No. 11. pp. 4599-4604.
@article{a6d803a404564ddb846758d06368c751,
title = "Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance",
abstract = "Intracellular metabolism of methotrexate (MTX) to MTX-polyglutamates (MTXPG) is one determinant of cytotoxicity. Steady-state accumulation of MTXPG seems to depend on the activity of two enzymes: folylpolyglutamate synthetase (FPGS), which adds glutamate residues, and γ-glutamyl hydrolase (GGH), which removes them. Overexpression of GGH would be expected to decrease intracellular MTXPG, thereby increasing efflux of MTX and decreasing cytotoxicity. Increased expression of GGH has been shown to be associated with resistance to MTX in human sarcoma cell lines and a rat hepatoma cell line. To clarify the specific role of GGH in determining MTX sensitivity, we investigated the phenotype produced by forced GGH overexpression in two cell types. Furthermore, because MTX and folic acid share metabolic pathways, we measured the effects of GGH overexpression on folic acid metabolism. The full-length cDNA for GGH, subcloned into a constitutive expression vector, was transfected into a human fibrosarcoma (HT-1080) and a human breast carcinoma (MCF-7) cell line. Compared with the clones containing an empty vector, the GGH-overexpressing cells express 15- to 30-fold more GGH mRNA, more GGH protein, and 15- to 90-fold more GGH enzyme activity. GGH overexpression altered MTX accumulation and metabolism to long-chain polyglutamates. In contrast to expectations, however, GGH overexpression did not confer resistance to short MTX exposures in either cell line. Changes in MTX metabolism were found to be balanced by alterations in accumulation and metabolism of folic acid. The ratio of MTX: folate accumulation may be a better predictor of MTX cytotoxicity than the accumulation of either alone. We conclude that, at least for these two cell lines, GGH overexpression alone is insufficient to produce clinical resistance to MTX.",
author = "Cole, {P. D.} and Kamen, {B. A.} and R. Gorlick and D. Banerjee and Smith, {A. K.} and E. Magill and Bertino, {J. R.}",
year = "2001",
month = "6",
day = "1",
language = "English (US)",
volume = "61",
pages = "4599--4604",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance

AU - Cole, P. D.

AU - Kamen, B. A.

AU - Gorlick, R.

AU - Banerjee, D.

AU - Smith, A. K.

AU - Magill, E.

AU - Bertino, J. R.

PY - 2001/6/1

Y1 - 2001/6/1

N2 - Intracellular metabolism of methotrexate (MTX) to MTX-polyglutamates (MTXPG) is one determinant of cytotoxicity. Steady-state accumulation of MTXPG seems to depend on the activity of two enzymes: folylpolyglutamate synthetase (FPGS), which adds glutamate residues, and γ-glutamyl hydrolase (GGH), which removes them. Overexpression of GGH would be expected to decrease intracellular MTXPG, thereby increasing efflux of MTX and decreasing cytotoxicity. Increased expression of GGH has been shown to be associated with resistance to MTX in human sarcoma cell lines and a rat hepatoma cell line. To clarify the specific role of GGH in determining MTX sensitivity, we investigated the phenotype produced by forced GGH overexpression in two cell types. Furthermore, because MTX and folic acid share metabolic pathways, we measured the effects of GGH overexpression on folic acid metabolism. The full-length cDNA for GGH, subcloned into a constitutive expression vector, was transfected into a human fibrosarcoma (HT-1080) and a human breast carcinoma (MCF-7) cell line. Compared with the clones containing an empty vector, the GGH-overexpressing cells express 15- to 30-fold more GGH mRNA, more GGH protein, and 15- to 90-fold more GGH enzyme activity. GGH overexpression altered MTX accumulation and metabolism to long-chain polyglutamates. In contrast to expectations, however, GGH overexpression did not confer resistance to short MTX exposures in either cell line. Changes in MTX metabolism were found to be balanced by alterations in accumulation and metabolism of folic acid. The ratio of MTX: folate accumulation may be a better predictor of MTX cytotoxicity than the accumulation of either alone. We conclude that, at least for these two cell lines, GGH overexpression alone is insufficient to produce clinical resistance to MTX.

AB - Intracellular metabolism of methotrexate (MTX) to MTX-polyglutamates (MTXPG) is one determinant of cytotoxicity. Steady-state accumulation of MTXPG seems to depend on the activity of two enzymes: folylpolyglutamate synthetase (FPGS), which adds glutamate residues, and γ-glutamyl hydrolase (GGH), which removes them. Overexpression of GGH would be expected to decrease intracellular MTXPG, thereby increasing efflux of MTX and decreasing cytotoxicity. Increased expression of GGH has been shown to be associated with resistance to MTX in human sarcoma cell lines and a rat hepatoma cell line. To clarify the specific role of GGH in determining MTX sensitivity, we investigated the phenotype produced by forced GGH overexpression in two cell types. Furthermore, because MTX and folic acid share metabolic pathways, we measured the effects of GGH overexpression on folic acid metabolism. The full-length cDNA for GGH, subcloned into a constitutive expression vector, was transfected into a human fibrosarcoma (HT-1080) and a human breast carcinoma (MCF-7) cell line. Compared with the clones containing an empty vector, the GGH-overexpressing cells express 15- to 30-fold more GGH mRNA, more GGH protein, and 15- to 90-fold more GGH enzyme activity. GGH overexpression altered MTX accumulation and metabolism to long-chain polyglutamates. In contrast to expectations, however, GGH overexpression did not confer resistance to short MTX exposures in either cell line. Changes in MTX metabolism were found to be balanced by alterations in accumulation and metabolism of folic acid. The ratio of MTX: folate accumulation may be a better predictor of MTX cytotoxicity than the accumulation of either alone. We conclude that, at least for these two cell lines, GGH overexpression alone is insufficient to produce clinical resistance to MTX.

UR - http://www.scopus.com/inward/record.url?scp=0035360869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035360869&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 4599

EP - 4604

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 11

ER -